Summary
Differentials
Common
- Alcohol induced
- Hepatic steatosis
- Primary biliary cholangitis (PBC)
- Primary sclerosing cholangitis
- Hemochromatosis
- Hodgkin lymphoma
- Non-Hodgkin lymphoma (NHL)
- Waldenström macroglobulinemia or lymphoplasmacytic lymphoma
- Acute myeloid leukemia (AML)
- Chronic myeloid leukemia (CML)
- Acute lymphoblastic leukemia (ALL)
- Chronic lymphocytic leukemia (CLL)
- Hairy cell leukemia
- Myelofibrosis
- Polycythemia vera
- Essential thrombocytosis
- Splenic metastases
- Autoimmune hemolytic anemia
- Rheumatoid arthritis (RA)
- Felty syndrome
- Systemic lupus erythematosus
- Sarcoidosis
- Malaria
- Epstein-Barr virus (EBV)
- Endocarditis
- Sepsis-related splenic abscesses
- Chronic hepatitis C
- Chronic hepatitis B
- Sickle cell anemia
- Cytoskeletal defects
- Thalassemias
Uncommon
- Benign splenic tumors
- Portal vein thrombosis
- Splenic vein thrombosis
- Budd-Chiari syndrome
- Hemophagocytic lymphohistiocytosis (HLH)
- Amyloidosis
- Gaucher or Niemann-Pick disease
- Severe dengue
- Splenic rupture
- Subcapsular hemorrhage
- Secondary to granulocyte colony-stimulating factor (G-CSF)
Contributors
Authors
Terri L. Parker, MD
Assistant Professor of Medicine
Section of Hematology
Yale School of Medicine
Smilow Cancer Center at Yale-New Haven
New Haven
CT
გაფრთხილება:
TLP declares that she has no competing interests.
მადლიერება
Dr Terri L. Parker would like to gratefully acknowledge Dr Alan E. Lichtin, the previous contributor to this monograph.
გაფრთხილება:
AEL has received research support from Amgen.
რეცენზენტები
Priyanka Mehta, MD
Consultant Haematologist
Bristol Haematology and Oncology Centre
Bristol
UK
გაფრთხილება:
PM declares that she has no competing interests.
Ruben A. Mesa, MD
Professor of Medicine
Mayo Clinic
Scottsdale
AZ
გაფრთხილება:
RAM declares that he has no competing interests.
Giovanni Barosi, MD
Director of the Laboratory of Clinical Epidemiology
IRCCS Policlinico S. Matteo Foundation
Pavia
Italy
გაფრთხილება:
GB declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
წყაროები
ძირითადი სტატიები
Gertz MA. Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management. Am J Hematol. 2023 Feb;98(2):348-58.სრული ტექსტი აბსტრაქტი
Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022 Jul;36(7):1720-48.სრული ტექსტი აბსტრაქტი
Shakoory B, Geerlinks A, Wilejto M, et al. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Ann Rheum Dis. 2023 Oct;82(10):1271-85.სრული ტექსტი აბსტრაქტი
Kowdley KV, Brown KE, Ahn J, et al. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019 Aug;114(8):1202-18.სრული ტექსტი აბსტრაქტი
გამოყენებული სტატიები
ამ თემაში მოხსენიებული წყაროების სრული სია ხელმისაწვდომია მომხმარებლებისთვის, რომლებსაც აქვთ წვდომა BMJ Best Practice-ის ყველა ნაწილზე.
პაციენტის ბროშურები
Hepatitis B: should I have the vaccine?
Hepatitis C: what is it?
მეტი პაციენტის ბროშურებიშედით სისტემაში ან გამოიწერეთ BMJ Best Practice
ამ მასალის გამოყენება ექვემდებარება ჩვენს განცხადებას